|
|
Boston Scientific Corporation (NYSE: BSX) |
|
|
|
| |
BSX's Net Income Growth by Quarter and Year
Boston Scientific's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BSX Net Income (in millions $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
| 4th Quarter |
December |
-
|
563.00
|
504.00
|
140.00
|
| 3rd Quarter |
September |
-
|
468.00
|
504.00
|
188.00
|
| 2nd Quarter |
June |
-
|
322.00
|
270.00
|
260.00
|
| 1st Quarter |
March |
672.00
|
493.00
|
314.00
|
110.00
|
| FY |
|
672.00
|
1,846.00
|
1,592.00
|
698.00
|
| BSX Net Income first quarter 2025 Y/Y Growth Comment |
Boston Scientific Corporation reported Net Income improvement of 36.31% year on year in the first quarter 2025, to $ 672.00 millions, this is lower than Boston Scientific Corporation's recent average Net Income surge of 158.24%.
Looking into first quarter 2025 results within Medical Equipment & Supplies industry 9 other companies have achieved higher Net Income growth. While Boston Scientific Corporation' s Net Income rise of 36.31% ranks overall at the positon no. 485 in the first quarter 2025.
|
| BSX Net Income ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
11.71 % |
260 % |
47.37 % |
| 3rd Quarter |
September |
- |
-7.14 % |
168.09 % |
-55.13 % |
| 2nd Quarter |
June |
- |
19.26 % |
3.85 % |
39.78 % |
| 1st Quarter |
March |
36.31 % |
57.01 % |
185.45 % |
-67.74 % |
| FY |
|
- |
15.95 % |
128.08 % |
-32.95 % |
BSX Net Income (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
| 4th Quarter |
December |
- |
20.3 % |
0 % |
-25.53 % |
| 3rd Quarter |
September |
- |
45.34 % |
86.67 % |
-27.69 % |
| 2nd Quarter |
June |
- |
-34.69 % |
-14.01 % |
136.36 % |
| 1st Quarter |
March |
19.36 % |
-2.18 % |
124.29 % |
15.79 % |
| FY (Year on Year) |
|
- |
15.95 % |
128.08 % |
-32.95 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 3000 % |
158.24 % |
-97.41 % |
|
|
|
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 3000 % |
158.24 % |
-97.41 % |
|
|
|
|
| Net Income by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Boston Scientific's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 3071.43 % |
95.58 % |
-99.72 % |
| (Dec 31 2019) |
|
|
| BSX's I. Quarter Q/Q Net Income Comment |
Boston Scientific Corporation achieved in the I. Quarter 2025 below company average Net Income jump of 19.36% quarter on quarter, to $ 672.00 millions.
I. Quarter 2025 Boston Scientific's results were contradictory, albeit beneath the average rise of 95.58 %, yet it shows a quite recovery compare to the -2.18% in the same quarter a year ago
Within Medical Equipment & Supplies industry 12 other companies have achieved higher Net Income quarter on quarter growth. While Boston Scientific's Net Income growth quarter on quarter, overall rank is 492. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 3071.43 % |
95.58 % |
-99.72 % |
| (Dec 31 2019) |
|
|
| BSX's I. Quarter Q/Q Net Income Comment |
Boston Scientific Corporation achieved in the I. Quarter 2025 below company average Net Income jump of 19.36% quarter on quarter, to $ 672.00 millions.
Even if the I. Quarter 2025 BSX's results were lower than the ordinary , it was still promising news, as the I. Quarter improvement, transcends the -2.18% Net Income growth in the same quarter a year ago
Within Medical Equipment & Supplies industry 12 other companies have achieved higher Net Income quarter on quarter growth. While Boston Scientific's Net Income growth quarter on quarter, overall rank is 492. |
|
Boston Scientific's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Mar 31 2025) |
12 Months Ending
(Dec 31 2024) |
12 Months Ending
(Sep 30 2024) |
12 Months Ending
(Jun 30 2024) |
12 Months Ending
(Mar 31 2024) |
| Cumulative Net Income 12 Months Ending |
$ 2,025.00 |
$ 1,846.00 |
$ 1,787.00 |
$ 1,823.00 |
$ 1,771.00 |
| Y / Y Net Income Growth (TTM) |
14.34 % |
15.95 % |
45.52 % |
99.89 % |
96.34 % |
| Year on Year Net Income Growth Overall
Ranking |
# 702 |
# 776 |
# 430 |
# 216 |
# 243 |
| Seqeuential Net Income Change (TTM) |
9.7 % |
3.3 % |
-1.97 % |
2.94 % |
11.24 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 702 |
# 776 |
# 430 |
# 216 |
# 243 |
| Cumulative Net Income growth Comment |
Assuming the Boston Scientific's fiscal year would have ended in Mar 31 2025, Boston Scientific would have reprted above average annual Net Income increase of 14.34% year on year, of $ 2,025 millions.
This marks a slow-down of the companys growth trends and from the 15.95% rise in Dec 31 2024.
Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 776. |
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1506.73 % |
-10.2 % |
-1022.68 % |
| (Dec 31 2018) |
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 21 |
| Sector |
# 58 |
| S&P 500 |
# 773 |
|
| Cumulative Net Income growth
Comment |
Assuming the Boston Scientific's fiscal year would have ended in Mar 31 2025, Boston Scientific would have reprted above average annual Net Income increase of 14.34% year on year, of $ 2,025 millions.
This marks a slow-down of the companys growth trends and from the 15.95% rise in Dec 31 2024.
Within the Healthcare sector 21 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 702, from total ranking in previous quarter at 776. |
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1506.73 % |
-10.2 % |
-1022.68 % |
| (Dec 31 2018) |
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 21 |
| Sector |
# 58 |
| S&P 500 |
# 773 |
|
62.37%